Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma.
Bech RS, Nielsen KL, Larsen TS, Bentzen HH, Lynggaard LS, Do TH, Braendstrup P, Brady J, Mikhaeel NG, Dybkaer K, Johnsen HE, Jensen P, Bøgsted M, El-Galaly TC. Bech RS, et al. Among authors: braendstrup p. Br J Haematol. 2018 Jul;182(2):297-301. doi: 10.1111/bjh.14775. Epub 2017 May 23. Br J Haematol. 2018. PMID: 28542714 Free article. No abstract available.
Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study.
Mylam KJ, Michaelsen TY, Hutchings M, Jacobsen Pulczynski E, Pedersen LM, Braendstrup P, Gade IL, Eberlein TR, Gang AO, Bøgsted M, Brown PN, El-Galaly TC. Mylam KJ, et al. Among authors: braendstrup p. Br J Haematol. 2017 Feb;176(4):671-673. doi: 10.1111/bjh.13988. Epub 2016 Feb 23. Br J Haematol. 2017. PMID: 26913572 Free article. No abstract available.
Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma.
Mortensen BK, Petersen SL, Kornblit B, Andersen PK, Braendstrup P, Andersen NS, Sengeløv H, Vindeløv L. Mortensen BK, et al. Among authors: braendstrup p. Eur J Haematol. 2012 Aug;89(2):151-9. doi: 10.1111/j.1600-0609.2012.01801.x. Epub 2012 Jun 25. Eur J Haematol. 2012. PMID: 22574687
(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.
Køllgaard T, Kornblit B, Petersen J, Klausen TW, Mortensen BK, Brændstrup P, Sengeløv H, Høgdall E, Müller K, Vindeløv L, Andersen MH, Thor Straten P. Køllgaard T, et al. Among authors: braendstrup p. PLoS One. 2016 Dec 20;11(12):e0168210. doi: 10.1371/journal.pone.0168210. eCollection 2016. PLoS One. 2016. PMID: 27997582 Free PMC article. Clinical Trial.
Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning.
Sengeløv H, Gerds TA, Brændstrup P, Kornblit B, Mortensen BK, Petersen SL, Vindeløv LL. Sengeløv H, et al. Among authors: braendstrup p. Bone Marrow Transplant. 2013 Sep;48(9):1185-91. doi: 10.1038/bmt.2013.38. Epub 2013 Mar 25. Bone Marrow Transplant. 2013. PMID: 23524638
Identification of a novel UTY-encoded minor histocompatibility antigen.
Mortensen BK, Rasmussen AH, Larsen ME, Larsen MV, Lund O, Braendstrup P, Harndahl M, Rasmussen M, Buus S, Stryhn A, Vindeløv L. Mortensen BK, et al. Among authors: braendstrup p. Scand J Immunol. 2012 Aug;76(2):141-50. doi: 10.1111/j.1365-3083.2012.02708.x. Scand J Immunol. 2012. PMID: 22536994 Free article.
38 results